Angioplasty Balloons Market

Angioplasty Balloons Market Size Survey Report – In a Glance

As per the survey report on global Angioplasty balloons market, the market is projected to foresee a CAGR of 3.4% between 2024-2033, and further generate a market size of USD 4.3 billion revenue by the end of 2033. In the year 2024, the market size was valued at USD 3.1 billion revenue.

• The global Angioplasty balloons market is projected to grow on account of the growing occurrence of heart ailments.
• In Japan, the Angioplasty balloons market growth can be attributed to the high-tech healthcare infrastructure.
• KDMI analyst’s growth analysis foresees elevated expense of next-generation technologies to challenge the market growth.
• North America, having the highest market share in the Angioplasty balloons market, is projected to dominate the global market.

Angioplasty Balloons Market Analysis

Angioplasty balloons are medical tools that clear blocked arteries during certain angioplasty procedures like percutaneous coronary interventions (PCIs). When inflated, it expands the narrowed arteries by pushing the plaques against artery walls improving blood circulation. Cardiovascular diseases (CVDs) stand as the foremost cause of death worldwide and are responsible for almost 17.9 million fatalities annually. Besides, with an increasing number of patients preferring minimally invasive treatments nowadays, healthcare providers and hospitals are progressively adopting devices such as angioplasty balloons more widely. Therefore, the growing occurrence of heart ailments, especially coronary artery disease, is boosting the demand for angioplasty balloons and is eventually contributing to the angioplasty balloons market.Medtronic, Boston Scientific Corporation, Johnson & Johnson Services, Inc., are some of the significant parties in the global market for Angioplasty balloons.

Analyst’s Observation on Japan Angioplasty Balloons Market Survey

Japan has always excelled in innovation and its recent healthcare technological developments are gaining global attention. Within the country, the market growth for angioplasty balloons is a result of the high-tech healthcare infrastructure. Japan holds the 17th rank in the Index for Science and Technology and grabs the 10th position in the healthcare R&D expenditure ranking list. The nation’s advanced healthcare system is propelling the angioplasty balloons market by supporting superior diagnostics, high-tech catheterization laboratories, and expert medical professionals. Abbott, Boston Scientific Corporation, Terumo Medical Corporation, are some of the significant parties in the market for Angioplasty balloons in Japan.

Angioplasty Balloons Market Growth Drivers and Challenges

Growth Drivers

Rising awareness of minimally invasive treatments:

The growing demand for minimally invasive procedures opens new avenues for the angioplasty balloons market. These techniques provide key advantages such as minimized complications, reduced recovery time, and decreased post-operative pain in comparison to traditional surgical approaches. Angioplasty balloons, especially those used in coronary artery bypass grafting (CABG) and other heart procedures support the trend by ensuring effective treatment with minimal surgical intrusions. Moreover, the growing use of angioplasty balloons in percutaneous coronary interventions (PCIs) reflects a heightened preference for less invasive options for patients. Percutaneous coronary interventions by means of drug-eluting stents (DES) are the top recommended treatment approach for most coronary artery lesions. Therefore, by reducing hospital stays and recovery durations, angioplasty balloons emerge as essential tools in improving cardiovascular care and market opportunities.

Ongoing advancements in balloon angioplasty techniques:

In the current era, the healthcare technology sector is booming. For instance, advancements in AI-driven technology are designed to improve clinical accuracy and boost efficiency in catheterization labs. Medical robots are also being widely adopted in minimally invasive surgical techniques. Roughly $1.8 trillion is allocated annually toward global healthcare efforts and worldwide healthcare expenses are expected to rise by double digits with an estimated 10.4% increase on average. Besides, progress in angioplasty balloon development has greatly influenced its market growth. The development of drug eluting balloons (DEBs) which release medication to prevent arterial re-narrowing has revolutionized treatment procedures. Additionally, improvements in high-pressure and non-compliant balloons have strengthened the safety and increased the precision of angioplasty. Therefore, these ongoing advancements in balloon angioplasty techniques are elevating the global angioplasty balloons sector.

Restraints

Elevated expense of next-generation technologies:

A key challenge in the angioplasty balloon market is the steep cost of cutting-edge balloon technologies, especially drug-eluting balloons (DEBs). Though these balloons enhance restenosis prevention, their cost compared to traditional angioplasty devices restricts broader adoption, especially in cost-conscious markets. Therefore, in regions with financial constraints, many healthcare providers opt for conventional balloons to control expenses, thereby, hindering the market.

Likelihood of health complications and surgical failures:

One major limitation in the angioplasty balloons industry is the risk of complications and treatment failures. While angioplasty is less invasive than traditional surgery, it still involves potential risks such as arterial narrowing, clot buildup, or vessel damage. Additionally, some patients may also experience negative reactions to such balloons which can damage the artery’s inner lining and cause further health issues, ultimately restricting the market growth.

Angioplasty Balloons Market Segmentation

Our experts at KD Market Insights have segmented the global Angioplasty balloons market research report as:

Angioplasty Balloons Market Regional Synopsis

North America is a major player in the global angioplasty balloons market. Its leadership stems from substantial healthcare investments, cutting-edge medical infrastructure, and an expanding senior population. The United States and Canada significantly contribute to market growth, leveraging advanced medical technologies and increased adoption of minimally invasive procedures. However, the United States dominates the North American angioplasty balloons market. Its market growth is supported by increasing cardiovascular disease cases, a well-established healthcare sector, and rising CAD (coronary artery disease) and PVD (peripheral vascular diseases) cases. Besides these, the widespread use of minimally invasive techniques, the presence of major medical device companies and modern medical technologies have further boosted the market growth.

Forecasts indicate that the Asia-Pacific angioplasty balloons market will experience rapid growth, driven by factors such as an aging population, upgrading healthcare infrastructure, and higher cardiovascular disease rates. Expansion is further spurred by broader access to modern treatments, heightened awareness of minimally invasive surgical options, and growing healthcare investments. Within the region, China is growing quickly, while Japan’s well-developed healthcare system and India’s rising urban areas’ demands contribute to the market growth. However, total healthcare spending in China is assumed to reach RMB 205 trillion yuan by 2030.

Europe is anticipated to see remarkable growth in its angioplasty balloons market over the given timeframe. The growth is mainly driven by factors such as an aging populace, growing rates of cardiovascular diseases, and strong healthcare infrastructure. Leading nations, like Germany, the United Kingdom, and France are at the forefront due to their advanced medical technologies and high adoption rates of interventional cardiology practices. In the UK, the market benefits from a comprehensive national health service that offers extensive access to advanced treatments, coupled with rising cases of coronary artery disease (CAD) and peripheral vascular diseases (PVD) and the move toward minimally invasive surgeries further propels the market in the region. Moreover, Germany’s market is bolstered by its sophisticated healthcare system and robust research environment.

In Latin America, the market for angioplasty balloons is on an upward trajectory, driven by factors such as effective adoption of less invasive techniques and increasing cardiovascular disease rates. Countries like Mexico, Brazil, and Argentina are experiencing a surge in demand due to better healthcare systems and growing awareness about heart health.

As per our analysts at KD Market Insights, the following five players lead the North America Angioplasty balloons market growth:

• Abbott (US)
• Boston Scientific Corporation (US)
• R. Bard (US)
• Cordis (Cardinal Health) (US)
• Cook (US)

Angioplasty Balloons Market Competitive Landscape

Some of the key players who top the global Angioplasty balloons market share:

• Medtronic
• Boston Scientific Corporation
• Johnson & Johnson Services, Inc.
• Abbott
• C. R. Bard, Inc.
• Spectranetics
• Terumo Medical Corporation
• Cardinal Health
• BIOTRONIK
• Cook Medical
• ENDOCOR GmbH
• B. Braun SE

1. Executive Summary
   1. Market Overview
   2. Key Findings
   3. Market Trends
   4. Market Outlook
2. Introduction
   1. Scope of the Report
   2. Research Methodology
   3. Definitions and Assumptions
   4. Acronyms and Abbreviations
3. Market Dynamics
   1. Drivers
   2. Restraints
   3. Opportunities
   4. Challenges
4. Global Angioplasty Balloons Market
   1. Market Overview
   2. Market Size and Forecast
   3. Market Segmentation
      1. By Type
      2. By Material
      3. By Balloon type
      4. By Disease indication
      5. By End-user
      6. By Region
5. Market Segmentation by Type
   1. 1. Plain Old Balloon Angioplasty
      2. Drug-Coated Balloon (DCB) Angioplasty
      3. Cutting Balloons
      4. Scoring Balloons
      5. Stent Graft Balloon Catheter
      6. Others
6. Market Segmentation by Material
   1. 1. Nylon
      2. Polyurethane
      3. Silicone Urethane Co-Polymers
      4. Other
7. Market Segmentation by Balloon type
   1. 1. Semi-Compliant
      2. Non-Compliant
      3. Others
8. Market Segmentation by Disease indication
   1. 1. Coronary Angioplasty
      2. Venous Angioplasty
      3. Carotid Angioplasty
      4. Renal Artery Angioplasty
      5. Peripheral Angioplasty
      6. Others
9. Market Segmentation by End-user
   1. 1. Cath Labs
      2. Hospitals
      3. Specialty Clinics
      4. Ambulatory Surgery Centers
      5. Diagnostic Centers
      6. Others
10. Regional Analysis
    1. North America
       1. United States
          1. Market Size and Forecast
          2. Key Trends and Developments
          3. Market Analysis by Type, Material, Balloon type, Disease indication and End-user
       2. Canada
          1. Market Size and Forecast
          2. Key Trends and Developments
          3. Market Analysis by Type, Material, Balloon type, Disease indication and End-user
       3. Mexico
          1. Market Size and Forecast
          2. Key Trends and Developments
          3. Market Analysis by Type, Material, Balloon type, Disease indication and End-user
    2. Europe
       1. United Kingdom
          1. Market Size and Forecast
          2. Key Trends and Developments
          3. Market Analysis by Type, Material, Balloon type, Disease indication and End-user
       2. Germany
          1. Market Size and Forecast
          2. Key Trends and Developments
          3. Market Analysis by Type, Material, Balloon type, Disease indication and End-user
       3. France
          1. Market Size and Forecast
          2. Key Trends and Developments
          3. Market Analysis by Type, Material, Balloon type, Disease indication and End-user
       4. Italy
          1. Market Size and Forecast
          2. Key Trends and Developments
          3. Market Analysis by Type, Material, Balloon type, Disease indication and End-user
       5. Spain
          1. Market Size and Forecast
          2. Key Trends and Developments
          3. Market Analysis by Type, Material, Balloon type, Disease indication and End-user
       6. Rest of Europe
          1. Market Size and Forecast
          2. Key Trends and Developments
          3. Market Analysis by Type, Material, Balloon type, Disease indication and End-user
    3. Asia Pacific
       1. China
          1. Market Size and Forecast
          2. Key Trends and Developments
          3. Market Analysis by Type, Material, Balloon type, Disease indication and End-user
       2. Japan
          1. Market Size and Forecast
          2. Key Trends and Developments
          3. Market Analysis by Type, Material, Balloon type, Disease indication and End-user
       3. India
          1. Market Size and Forecast
          2. Key Trends and Developments
          3. Market Analysis by Type, Material, Balloon type, Disease indication and End-user
       4. Australia
          1. Market Size and Forecast
          2. Key Trends and Developments
          3. Market Analysis by Type, Material, Balloon type, Disease indication and End-user
          4. South Korea
          5. Market Size and Forecast
          6. Key Trends and Developments
          7. Market Analysis by Type, Material, Balloon type, Disease indication and End-user
       5. Rest of Asia Pacific
          1. Market Size and Forecast
          2. Key Trends and Developments
          3. Market Analysis by Type, Material, Balloon type, Disease indication and End-user
    4. Latin America
       1. Brazil
          1. Market Size and Forecast
          2. Key Trends and Developments
          3. Market Analysis by Type, Material, Balloon type, Disease indication and End-user
       2. Argentina
          1. Market Size and Forecast
          2. Key Trends and Developments
          3. Market Analysis by Type, Material, Balloon type, Disease indication and End-user
       3. Colombia
          1. Market Size and Forecast
          2. Key Trends and Developments
          3. Market Analysis by Type, Material, Balloon type, Disease indication and End-user
       4. Rest of Latin America
          1. Market Size and Forecast
          2. Key Trends and Developments
          3. Market Analysis by Type, Material, Balloon type, Disease indication and End-user
    5. Middle East & Africa
       1. South Africa
          1. Market Size and Forecast
          2. Key Trends and Developments
          3. Market Analysis by Type, Material, Balloon type, Disease indication and End-user
       2. Saudi Arabia
          1. Market Size and Forecast
          2. Key Trends and Developments
          3. Market Analysis by Type, Material, Balloon type, Disease indication and End-user
       3. UAE
          1. Market Size and Forecast
          2. Key Trends and Developments
          3. Market Analysis by Type, Material, Balloon type, Disease indication and End-user
       4. Rest of Middle East & Africa
          1. Market Size and Forecast
          2. Key Trends and Developments
          3. Market Analysis by Type, Material, Balloon type, Disease indication and End-user
11. Competitive Landscape
    1. Market Share Analysis
    2. Company Profiles
    3. Medtronic
    4. Boston Scientific Corporation
    5. Johnson & Johnson Services, Inc.
    6. Abbott
    7. C. R. Bard, Inc.
    8. Spectranetics
    9. Terumo Medical Corporation
    10. Cardinal Health
    11. BIOTRONIK
    12. Cook Medical
12. Strategic Recommendations
13. Appendix
    1. List of Tables
    2. List of Figures
14. References